Stock Research for HOLL

HOLL

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

HOLL Stock Chart & Research Data

The HOLL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the HOLL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


HOLL Due diligence Resources & Stock Charts

The HOLL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View HOLL Detailed Price Forecast - CNN Money CNN View HOLL Detailed Summary - Google Finance
Yahoo View HOLL Detailed Summary - Yahoo! Finance Zacks View HOLL Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View HOLL Trends & Analysis - Trade-Ideas Barrons View HOLL Major Holders - Barrons
NASDAQ View HOLL Call Transcripts - NASDAQ Seeking View HOLL Breaking News & Analysis - Seeking Alpha
Spotlight View HOLL Annual Report - CompanySpotlight.com OTC Report View HOLL OTC Short Report - OTCShortReport.com
TradeKing View HOLL Fundamentals - TradeKing Charts View HOLL SEC Filings - Bar Chart
WSJ View Historical Prices for HOLL - The WSJ Morningstar View Performance/Total Return for HOLL - Morningstar
MarketWatch View the Analyst Estimates for HOLL - MarketWatch CNBC View the Earnings History for HOLL - CNBC
StockMarketWatch View the HOLL Earnings - StockMarketWatch MacroAxis View HOLL Buy or Sell Recommendations - MacroAxis
Bullish View the HOLL Bullish Patterns - American Bulls Short Pains View HOLL Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View HOLL Stock Mentions - StockTwits PennyStocks View HOLL Stock Mentions - PennyStockTweets
Twitter View HOLL Stock Mentions - Twitter Invest Hub View HOLL Investment Forum News - Investor Hub
Yahoo View HOLL Stock Mentions - Yahoo! Message Board Seeking Alpha View HOLL Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for HOLL - SECform4.com Insider Cow View Insider Transactions for HOLL - Insider Cow
CNBC View HOLL Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for HOLL - OTC Markets
Yahoo View Insider Transactions for HOLL - Yahoo! Finance NASDAQ View Institutional Holdings for HOLL - NASDAQ


Stock Charts

FinViz View HOLL Stock Insight & Charts - FinViz.com StockCharts View HOLL Investment Charts - StockCharts.com
BarChart View HOLL Stock Overview & Charts - BarChart Trading View View HOLL User Generated Charts - Trading View




Latest Financial News for HOLL


Hollywood Media Changes Name and Stock Symbol to NovelStem International Corp. and “NSTM” to Reflect Focus on Stem Cell-Based Diagnostics to Better Select Cancer Chemotherapies
Posted on Tuesday September 25, 2018

Hollywood Media Corp. (OTC Pink: HOLL) announced today it has changed its corporate name to NovelStem International Corp. and that its common stock will commence trading under a new OTC Pink symbol “NSTM” and new CUSIP number 67001V109, effective September 26, 2018. The NovelStem International name reflects the Company’s strategic transformation through a July 2018 acquisition of an initial 20% stake in Jerusalem, Israel-based NewStem Ltd. (view acquisition press release). The Company is now focused on NewStem’s novel stem cell-based diagnostic technology and has the right to increase its NewStem ownership up to 33% based on the completion of up to $2 million in follow-on contributions.


NewStem Announces $4 million Seed Investment
Posted on Sunday July 15, 2018

JERUSALEM, July 16, 2018 /PRNewswire/ --  NewStem Ltd., a Jerusalem-based biotech with a novel precision-medicine technology that can increase chemotherapy's effectiveness, today announced a $4 million seed financing from a publicly-traded US-based company to be named NovelStem International Corp. NewStem is a spinoff of Yissum, The Technology Transfer Company of The Hebrew University. Drug resistance is a major cause of treatment failure in cancer chemotherapy.



Posted on Wednesday December 31, 1969



Posted on Wednesday December 31, 1969


Stock Market & Investing Books

Enter a stock symbol to view the stock details.